Sar1-Ile8-Angiotensin-II
Latest Information Update: 20 Dec 2000
At a glance
- Originator Daiichi Pharmaceutical
- Class Angiotensins; Antihypertensives; Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer
Most Recent Events
- 20 Dec 2000 Discontinued-Clinical for Bladder cancer in Japan (Intra-arterial)